We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

FNKO:NASDAQFunko, Inc. Analysis

Data as of 2026-04-04 - not real-time

$3.25

Latest Price

8/10Risk

Risk Level: High

Executive Summary

Funko’s stock is trading at $3.25, hovering just above the computed support level of $2.90 and well below the resistance of $4.74. The 20‑day and 200‑day simple moving averages (~$3.67) sit slightly above the current price, while the 50‑day SMA (~$4.06) remains higher, indicating a short‑term price lag. A 14‑day RSI of 37 suggests the shares are edging toward oversold territory, yet the MACD line remains beneath the signal line, producing a bearish histogram. Volume has been on a decreasing trend, and the 30‑day realized volatility exceeds 80%, underscoring a choppy trading environment. The computed beta of roughly 2.45 points to amplified movements relative to the market, amplifying both upside and downside potential.
On the fundamentals side, the company posted a 7% YoY revenue decline to $273 million in Q4 but beat consensus with a non‑GAAP profit of $0.05 per share. European point‑of‑sale growth accelerated 20% year‑over‑year, while U.S. sales turned positive in the latest quarter, providing a regional tailwind. FY2026 guidance calls for flat‑to‑up‑3% net sales, with core product lines expected to climb high‑single‑digit percentages and the Loungefly brand slated for a double‑digit decline. The forward P/E of 22.4 and a price‑to‑book below 1.0 suggest the market is pricing the stock at a discount to its book value. However, negative operating cash flow, a debt‑to‑equity ratio above 150%, and a historic max drawdown of over 56% raise solvency concerns. Given the mix of modest near‑term upside, undervalued valuation metrics, and elevated risk factors, the stock sits at a crossroads between a potential rebound and continued volatility. Investors should weigh the strong brand franchise and European momentum against the high leverage and cash‑flow shortfall before committing capital.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • bearish MACD histogram
  • price near support with limited upside
  • decreasing trading volume

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • forward EPS turning positive
  • price-to-book below 1.0 indicating undervaluation
  • European sales momentum

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • high debt-to-equity and negative cash flow
  • cyclical consumer discretionary exposure
  • brand franchise with growth potential

Key Metrics & Analysis

Financial Health

Revenue Growth-7.00%
Profit Margin-7.42%
P/E Ratio22.4
ROE-32.33%
ROA-4.09%
Debt/Equity157.30
P/B Ratio1.0
Op. Cash Flow$-5120000
Free Cash Flow$-2740500

Technical Analysis

TrendNeutral
RSI37.2
Support$2.90
Resistance$4.74
MA 20$3.67
MA 50$4.06
MA 200$3.66
MACDBearish
VolumeDecreasing
Fear & Greed Index78.8

Valuation

Target Price$4.50
Upside/Downside38.46%
GradeUndervalued
TypeValue

Risk Assessment

Beta2.45
Volatility80.77%
Sector RiskHigh
Reg. RiskLow
Geo RiskMedium
Currency RiskMedium
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.